Carbamylated proteins activate glomerular mesangial cells and stimulate collagen deposition

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 3, 1999, Pages 302-308

  Shaykh, M ^a,b,c   Pegoraro, A A ^a,b,c   Mo, W ^a,b,c   Arruda, J A L ^a,b,c   Dunea, G ^a,b,c   Singh, Ashok K ^a,b,c  

^a Hektoen Institute for Medical Research   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMYLATED PROTEIN; CELL PROLIFERATION; COLLAGEN; ENZYME IMMUNOASSAY; FLUORESCENCE ANALYSIS; GELATINASE; IN VITRO STUDY; MESANGIUM CELL; PROTEIN SYNTHESIS; THYMIDINE; ZYMOGRAPHY;

EID: 0033106092     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90086-0     Document Type: Article

References (42)

1. 1. Stark GR, Stein WH, Moore S. Reaction of cyanate present in aqueous urea with amino acids and proteins. J Biol Chem 1960;235:3177-81.
2. 2. Cerami A, Allen TA, Graziano JH, deFuria FG, Manning JM, Gillette PN. Pharmacology of cyanate I. General effects on experimental animals. J Pharmacol Exp Ther 1973;185:653-66.
3. 3. Whitaker JR, Fujimaki M, editors. Chemical deterioration of proteins. CRC symposium series 123. Washington DC: American Chemical Society; 1980. p. 80.
4. 4. Jensen M, Nathan DG, Bunn HF. The reaction of cyanate with the α and β subunits in hemoglobins: effects of oxygenation, phosphates and carbon dioxide. J Biol Chem 1973;248:8057-63.
5. 5. Roxborough HE, Millar CA, McEneny J, Young IS. Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Biochem Biophys Res Commun 1995;214:1073-8.
6. 6. Satake R, Kozutsumi H, Takeuchi M, Asano K. Chemical modification of erythropoietin: an increase in in vivo activity by guanidination. Biochim Biophys Acta 1990;1038:125-9.
7. 7. Oimomi M, Hatanaka H, Yoshimura Y, Yokono K, Baba S, Taketomi Y. Carbamylation of insulin and its biological activity. Nephron 1987;46:63-6.
8. 8. Oimomi M, Matsumoto S, Hatanaka H, Ishikawa, Kubota S, Yoshimura Y, et al. Determination of carbamylated plasma protein and its clinical application to renal failure. Nephron 1985;40:405-6.
9. 9. Stim J, Shaykh M, Anwar F, Ansari A, Arruda JAL, Dunea G. Factors determining hemoglobin carbamylation in renal failure. Kidney Int 1995;48:1605-10.
10. 10. Leehey DJ, Song RH, Alavi N, Singh AK. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995;44:929-35.
11. 11. Williams RC Jr. Preparation and purification of carbamylated intermediates of human hemoglobin. Biochem Biophys Res Commun 1975;62:118-28.
12. 12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
13. 13. Kasinath BS, Singh AK, Kanwar YS, Lewis EJ. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells. Am J Physiol (Renal Fluid Electrolyte Physiol) 1988;255:F590-6.
14. 14. Kasinath BS, Singh AK, Kanwar YS, Lewis EJ. Dexamethasone increases heparan sulfate core protein content of glomerular epithelial cells. J Lab Clin Med 1990;115:196-202.
15. 15. Davenport A, Jones S, Goel S, Astley JP, Feest TG. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in endstage renal failure. Kidney Int 1996;50:1344-51.
16. 16. Ramponi G, Leaver JL, Grisolia S. Homocitrulline formation following carbamylation of histones with carbamyl phosphate. FEBS Lett 1971;16:311-4.
17. 17. Kuckel CL, Lubit BW, Lambooy PK, Farnsworth PN. Methylisocyanate and actin polymerization: the in vitro effects of carbamylation. Biochim Biophys Acta 1993;1162:143-8.
18. 18. Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA. Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int 1992;41:1175-81.
19. 19. Fazili KM, Mir MM, Qasim MA. Changes in protein stability upon chemical modification of lysine residues of bovine serum albumin by different reagents. Biochem Mol Biol Int 1993;31:807-16.
20. 20. Dengler TJ, Robertz-Vaupel GM, Dengler HJ. Albumin binding in uremia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin. Eur J Clin Pharmacol 1992;43:491-9.
21. 21. Aguirre C, Calvo R, Sasiain R. Unchanged protein binding of penbutolol in renal insufficiency: a possible role of carbamylation. Int J Pharmacol Ther Toxicol 1993;31:31-4.
22. 22. Roxborough HE, Young IS. Carbamylation of proteins and atherogenesis in renal failure. Med Hypotheses 1995;45:125-8.
23. 23. Berlyne GM. Carbamylated proteins and peptides in health and uremia. Nephron 1998;79:125-30.
24. 24. Balion CM, Draisey TF, Thibert RJ. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. 1998;53:488-95.
25. 25. Foidart JM, Foidart JB, Mahieu PR. Synthesis of collagen and fibronectin by glomerular cells in culture. Renal Physiol 1980;3:183-90.
26. 26. Haralson MA, Jacobson HR, Hoover RL. Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 1987;57:513-23.
27. 27. Lovett JM, Strerzel RB, Kashgarian M, Ryan JL. Neutral proteinase activity produced in vitro by cells of glomerular mesangium. Kidney Int 1983;23:342-9.
28. 28. Raugi GJ, Lovett DH. Thrombospondin secretion in the cultured human glomerular mesangial cells. Am J Pathol 1986;129:364-72.
29. 29. Mene P, Simonson MS, Dunn MJ. Physiology of the mesangial cell. Physiol Rev 1989;69:1347-424.
30. 30. Foidart JB, Prad YS, Winand RJ, Mahieu PR. Tissue culture of normal rat glomeruli. Renal Physiol 1980;3:169-73.
31. 31. Ishimura E, Sterzel RB, Budde K, Kashgarian M. Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol 1989;134:843-55.
32. 32. Pricci F, Puglicse G, Romano G, Romeo G, Locuratolo N, Pugliese F, et al. Insulin-like growth factors I and II stimulate extracellular matrix production in human glomerular mesangial cells. Comparison with transforming growth factor b. Endocrinol 1996;137:879-85.
33. 33. Anderson PW, Zhang XY, Tian J, Correale JD, Xi XP, Yang D, et al. Insulin and angiotensin II are additive in stimulating TGF-B1 and matrix mRNAs in mesangial cells. Kidney Int 1996;50:745-53.
34. 34. Ebihara I, Suzuki S, Nakamura T, Fukui M, Yaguchi I, Tomino Y, et al. Extracellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis. J Am Soc Nephrol 1993;3:1387-97.
35. 35. Lundblad RL, editor. Techniques in protein modification. Boca Raton, FL: CRC Press; 1955. p. 54.
36. 36. Singh AK. Role of glycated proteins in complications of diabetes [editorial]. Kidney: a current survey of world literature 1996;5:153-5.
37. 37. Giardino I, Edelstein D, Brownlee M. Non-enzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin Invest 1994;94:110-7.
38. 38. Ding G, van Goor H, Ricardo SD, Orlowski JM, Diamond JR. Oxidized LDL stimulates the expression on TGF-beta and fibronectin in human glomerular epithelial cells. Kidney Int 1997;51:147-54.
39. 39. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker L. Receptor specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated by platelet-derived growth factor. Proc Natl Acad Sci 1992;89:2873-7.
40. 40. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycosylation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 1994;91:11704-8.
41. 41. Gosporadowicz D, Moran JS. Growth factors in mammalian cell culture. Ann Rev Biochem 1977;45:531-58.
42. 42. Floege J, Eng E, Young BA, Johnson RJ. Factors involved in regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 1993;39(suppl):S47-54.